论文部分内容阅读
AIM To investigate the safety and efficacy of S-1 plus oxaliplatin(SOX)as an adjuvant chemotherapy regimen in gastric cancer(GC)after D2 dissection.METHODS GC Patients who underwent D2 gastrectomy from September 2009 to December 2011 in four Chinese insti